Azithromycin recall in Canada: potential cancer relapse risk
In plain language
This recall involves information about the long-term use of azithromycin (Zithromax) in Canada. It's being updated due to a potential risk of cancer relapse in certain patients after stem cell transplants. Patients should talk to their doctor if they have concerns about using this medication.
What to do
- Talk to your doctor if you are using azithromycin and have concerns.
- Healthcare professionals should avoid prescribing long-term azithromycin for certain patients.
- Report any health or safety concerns to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Why this matters
Potential cancer relapse risk
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
Potential cancer relapse risk
What should consumers do?
Talk to your doctor if you are using azithromycin and have concerns. Healthcare professionals should avoid prescribing long-term azithromycin for certain patients. Report any health or safety concerns to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Potential cancer relapse risk
When was this product recalled?
This product was recalled on August 13, 2018.
Is the Azithromycin (Zithromax) brand affected by this recall?
Yes, Azithromycin (Zithromax) products are affected by this recall. This recall involves information about the long-term use of azithromycin (Zithromax) in Canada. It's being updated due to a potential risk of cancer relapse in certain patients after stem cell transplants. Patients should talk to their doctor if they have concerns about using this medication.